Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
暂无分享,去创建一个
[1] Z. Hall. Cancer , 1906, The Hospital.
[2] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[3] A. Chadli. THE CANCER CELL , 1924, La Presse medicale.
[4] K. Hagino-Yamagishi,et al. [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.
[5] S. Pilkis,et al. Rat liver 6‐phosphofructo 2‐kinase/ fructose 2,6‐bisphosphatase: A review of relationships between the two activities of the enzyme , 1984, Journal of cellular biochemistry.
[6] A. Lehninger. Principles of Biochemistry , 1984 .
[7] T Jones,et al. Glucose utilization in vivo by human pulmonary neoplasms , 1987, Cancer.
[8] M. Snyder,et al. Glucose induces cAMP-independent growth-related changes in stationary-phase cells of Saccharomyces cerevisiae. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[9] AC Tose. Cell , 1993, Cell.
[10] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[11] M. V. Heiden,et al. Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. , 1999, Molecular cell.
[12] B. Devlin,et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.
[13] David R. Plas,et al. Growth Factors Can Influence Cell Growth and Survival through Effects on Glucose Metabolism , 2001, Molecular and Cellular Biology.
[14] I. Tomlinson,et al. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase , 2003, Annals of medicine.
[15] A. Alavi,et al. Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.
[16] E. Calle,et al. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.
[17] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[18] K. Wirtz,et al. "Wages of fear": transient threefold decrease in intracellular ATP level imposes apoptosis. , 2004, Biochimica et biophysica acta.
[19] S. Weinhouse,et al. The Warburg hypothesis fifty years later , 2004, Zeitschrift für Krebsforschung und Klinische Onkologie.
[20] Lewis C Cantley,et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[21] S. Gottschalk,et al. Imatinib (STI571)-Mediated Changes in Glucose Metabolism in Human Leukemia BCR-ABL-Positive Cells , 2004, Clinical Cancer Research.
[22] R. Deberardinis,et al. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation , 2005, Oncogene.
[23] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .
[24] David G. Watson,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase , 2005 .
[25] Chi Li,et al. Growth Factor Regulation of Autophagy and Cell Survival in the Absence of Apoptosis , 2005, Cell.
[26] Daniel E Bauer,et al. ATP citrate lyase inhibition can suppress tumor cell growth. , 2005, Cancer cell.
[27] Dario R Alessi,et al. Metformin and reduced risk of cancer in diabetic patients , 2005, BMJ : British Medical Journal.
[28] L. Alberghina,et al. Ras-dependent carbon metabolism and transformation in mouse fibroblasts , 2006, Oncogene.
[29] Eyal Gottlieb,et al. TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.
[30] P. Leder,et al. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.
[31] Steven L McKnight,et al. Restriction of DNA Replication to the Reductive Phase of the Metabolic Cycle Protects Genome Integrity , 2007, Science.
[32] D. Beach,et al. A high glycolytic flux supports the proliferative potential of murine embryonic stem cells. , 2006, Antioxidants & redox signaling.
[33] R. Deberardinis,et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.
[34] Nicola Zamboni,et al. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells , 2007, The Journal of cell biology.
[35] D. Hardie,et al. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy , 2007, Nature Reviews Molecular Cell Biology.
[36] Emma Saavedra,et al. Energy metabolism in tumor cells , 2007, The FEBS journal.
[37] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[38] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[39] Julien Verrax,et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.
[40] Ru Wei,et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.
[41] Ralph Weissleder,et al. Effective Use of PI3K and MEK Inhibitors to Treat Mutant K-Ras G12D and PIK3CA H1047R Murine Lung Cancers , 2008, Nature Medicine.
[42] M. Pollak,et al. Insulin and insulin-like growth factor signalling in neoplasia , 2008, Nature Reviews Cancer.
[43] Anthony Mancuso,et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.
[44] H. Christofk,et al. Pyruvate kinase M2 is a phosphotyrosine-binding protein , 2008, Nature.
[45] D. Sabatini,et al. Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.
[46] C. Thompson,et al. Metabolic enzymes as oncogenes or tumor suppressors. , 2009, The New England journal of medicine.
[47] S. Ben-Haim,et al. 18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response* , 2008, Journal of Nuclear Medicine.
[48] R. Rosenfeld. Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[49] Jennifer E. Van Eyk,et al. c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.
[50] A. Marchetti,et al. IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high‐grade gliomas but not in other solid tumors , 2009, Human mutation.
[51] R. McLendon,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[52] J Nucl Med , 2010 .